Trgovina ALX Oncology Holdings Inc. - ALXO CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 0.05 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
| Čas nočne pristojbine | 21:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Ključni statistični podatki
| Predhodno. Zapri* | 4.83 |
| Odpri* | 4.87 |
| Enoletna sprememba* | -72.42% |
| Dnevni razpon* | 4.78 - 5.01 |
| Razpon 52 wk | 4.52-19.85 |
| Povprečni obseg (10 dni) | 377.99K |
| Povprečni obseg (3 meseci) | 4.88M |
| Tržna kapitalizacija | 203.37M |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 40.86M |
| Prihodki | N/A |
| EPS | -3.03 |
| Dividenda (donosnost v %) | N/A |
| Beta | -100.00K |
| Datum naslednjega zaslužka | May 8, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| Mar 28, 2023 | 4.83 | 0.04 | 0.84% | 4.79 | 5.03 | 4.77 |
| Mar 27, 2023 | 4.96 | 0.36 | 7.83% | 4.60 | 5.02 | 4.52 |
| Mar 24, 2023 | 4.63 | -0.13 | -2.73% | 4.76 | 4.84 | 4.54 |
| Mar 23, 2023 | 4.83 | 0.29 | 6.39% | 4.54 | 4.87 | 4.54 |
| Mar 22, 2023 | 4.78 | -0.04 | -0.83% | 4.82 | 4.95 | 4.63 |
| Mar 21, 2023 | 4.79 | 0.09 | 1.91% | 4.70 | 5.02 | 4.68 |
| Mar 20, 2023 | 4.60 | -0.16 | -3.36% | 4.76 | 4.78 | 4.49 |
| Mar 17, 2023 | 4.76 | -0.15 | -3.05% | 4.91 | 4.95 | 4.63 |
| Mar 16, 2023 | 4.98 | -0.08 | -1.58% | 5.06 | 5.13 | 4.92 |
| Mar 15, 2023 | 5.17 | 0.09 | 1.77% | 5.08 | 5.38 | 4.67 |
| Mar 14, 2023 | 5.23 | -0.49 | -8.57% | 5.72 | 5.74 | 5.07 |
| Mar 13, 2023 | 5.60 | 0.42 | 8.11% | 5.18 | 5.90 | 5.18 |
| Mar 10, 2023 | 5.36 | -0.33 | -5.80% | 5.69 | 5.73 | 5.02 |
| Mar 9, 2023 | 5.84 | -0.27 | -4.42% | 6.11 | 6.19 | 5.60 |
| Mar 8, 2023 | 6.21 | -0.16 | -2.51% | 6.37 | 6.39 | 6.11 |
| Mar 7, 2023 | 6.37 | 0.07 | 1.11% | 6.30 | 6.54 | 6.29 |
| Mar 6, 2023 | 6.44 | -0.04 | -0.62% | 6.48 | 6.48 | 6.20 |
| Mar 3, 2023 | 6.50 | 0.19 | 3.01% | 6.31 | 6.67 | 6.31 |
| Mar 2, 2023 | 6.45 | 0.11 | 1.74% | 6.34 | 6.47 | 6.23 |
| Mar 1, 2023 | 6.48 | 0.04 | 0.62% | 6.44 | 6.60 | 6.43 |
ALX Oncology Holdings Inc. Events
| Čas (UTC) (UTC) | Država | Dogodek |
|---|---|---|
| No events scheduled | ||
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Skupni prihodki | 0 | 0 | 1.182 | 4.796 | 2.067 |
| Prihodki | 0 | 0 | 1.182 | 4.796 | 2.067 |
| Celotni stroški prihodkov | 0 | 1.075 | 4.36 | 1.88 | |
| Bruto dobiček | 0 | 0.107 | 0.436 | 0.187 | |
| Celotni odhodki iz poslovanja | 127.436 | 83.555 | 45.466 | 23.979 | 15.751 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 29.036 | 23.385 | 14.809 | 3.313 | 2.601 |
| Raziskave in razvoj | 98.4 | 60.17 | 28.961 | 16.306 | 11.27 |
| Prihodki iz poslovanja | -127.436 | -83.555 | -44.284 | -19.183 | -13.684 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 4.278 | -0.013 | -0.811 | -0.021 | 0 |
| Drugo, neto | -0.26 | 0.084 | -0.404 | -0.005 | -0.002 |
| Čisti dobiček pred obdavčitvijo | -123.418 | -83.484 | -45.499 | -19.209 | -13.686 |
| Čisti dobiček po davkih | -123.482 | -83.463 | -45.74 | -19.243 | -13.731 |
| Čisti dobiček pred dodatnimi postavkami | -123.482 | -83.463 | -45.74 | -19.243 | -13.731 |
| Čisti dobiček | -123.482 | -83.463 | -45.74 | -19.243 | -13.731 |
| Total Adjustments to Net Income | 0 | 0 | -5.202 | -4.028 | -3.671 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -123.482 | -83.463 | -50.942 | -23.271 | -17.402 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -123.482 | -83.463 | -50.942 | -23.271 | -17.402 |
| Popravljen čisti dobiček | -123.482 | -83.463 | -50.942 | -23.271 | -17.402 |
| Popravljene ponderirane povprečne delnice | 40.6996 | 40.308 | 18.4853 | 34.7116 | 34.7116 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -3.03398 | -2.07063 | -2.7558 | -0.67041 | -0.50133 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
| Popravljen normalizirani dobiček na enoto čistega dobička | -3.03398 | -2.07063 | -2.73397 | -0.67041 | -0.50133 |
| Nenavadni odhodki (prihodki) | 0 | 0 | 0.621 |
| Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
| Prihodki | 0 | ||||
| Celotni odhodki iz poslovanja | 32.219 | 36.681 | 33.789 | 24.747 | 28.472 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 7.022 | 7.299 | 7.041 | 7.674 | 7.578 |
| Raziskave in razvoj | 25.197 | 29.382 | 26.748 | 17.073 | 20.894 |
| Prihodki iz poslovanja | -32.219 | -36.681 | -33.789 | -24.747 | -28.472 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 1.807 | 1.37 | 0.876 | 0.225 | -0.003 |
| Drugo, neto | -0.233 | -0.009 | -0.007 | -0.011 | 0.016 |
| Čisti dobiček pred obdavčitvijo | -30.645 | -35.32 | -32.92 | -24.533 | -28.459 |
| Čisti dobiček po davkih | -30.709 | -35.32 | -32.92 | -24.533 | -28.438 |
| Čisti dobiček pred dodatnimi postavkami | -30.709 | -35.32 | -32.92 | -24.533 | -28.438 |
| Čisti dobiček | -30.709 | -35.32 | -32.92 | -24.533 | -28.438 |
| Total Adjustments to Net Income | 0 | ||||
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -30.709 | -35.32 | -32.92 | -24.533 | -28.438 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -30.709 | -35.32 | -32.92 | -24.533 | -28.438 |
| Popravljen čisti dobiček | -30.709 | -35.32 | -32.92 | -24.533 | -28.438 |
| Popravljene ponderirane povprečne delnice | 40.7459 | 40.747 | 40.6878 | 40.6163 | 40.5297 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.75367 | -0.86681 | -0.80909 | -0.60402 | -0.70166 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.75367 | -0.86681 | -0.80909 | -0.60402 | -0.70166 |
| Celotni stroški prihodkov | |||||
| Bruto dobiček | |||||
| Nenavadni odhodki (prihodki) | 0 | 0 |
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 367.019 | 435.992 | 9.809 | 10.208 |
| Denarna sredstva in kratkoročne naložbe | 363.667 | 434.219 | 9.017 | 8.262 |
| Cash | 434.219 | 9.017 | 8.262 | |
| Celotne terjatve, neto | 0 | 0.536 | 0.932 | |
| Accounts Receivable - Trade, Net | 0 | 0.536 | 0.932 | |
| Prepaid Expenses | 3.352 | 1.773 | 0.256 | 1.014 |
| Total Assets | 380.183 | 436.054 | 10.676 | 11.164 |
| Property/Plant/Equipment, Total - Net | 3.397 | 0.052 | 0.86 | 0.956 |
| Property/Plant/Equipment, Total - Gross | 3.46 | 0.077 | 2.309 | 1.976 |
| Accumulated Depreciation, Total | -0.063 | -0.025 | -1.449 | -1.02 |
| Other Long Term Assets, Total | 9.767 | 0.01 | 0.007 | 0 |
| Total Current Liabilities | 15.295 | 6.204 | 4.984 | 1.873 |
| Accounts Payable | 3.764 | 0.004 | 3.748 | 0.697 |
| Accrued Expenses | 11.102 | 6.049 | 1.046 | 0.905 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 0.151 | 0.19 | 0.271 | |
| Total Liabilities | 17.134 | 6.209 | 10.952 | 2.009 |
| Total Long Term Debt | 0.28 | 0 | 5.421 | 0 |
| Long Term Debt | 5.421 | 0 | ||
| Other Liabilities, Total | 1.559 | 0.005 | 0.547 | 0.136 |
| Total Equity | 363.049 | 429.845 | -0.276 | 9.155 |
| Preferred Stock - Non Redeemable, Net | 70.363 | 60.933 | ||
| Common Stock | 0.041 | 0.04 | 0.021 | 0.021 |
| Additional Paid-In Capital | 564.993 | 548.327 | 2.122 | 1.74 |
| Retained Earnings (Accumulated Deficit) | -201.985 | -118.522 | -72.782 | -53.539 |
| Total Liabilities & Shareholders’ Equity | 380.183 | 436.054 | 10.676 | 11.164 |
| Total Common Shares Outstanding | 40.5871 | 39.8445 | 34.7116 | 34.7116 |
| Redeemable Preferred Stock | 0 | |||
| Denarna sredstva in ustrezniki | 363.667 | |||
| Current Port. of LT Debt/Capital Leases | 0.429 | |||
| Capital Lease Obligations | 0.28 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 321.525 | 367.019 | 388.963 | 412.277 | 432.327 |
| Denarna sredstva in kratkoročne naložbe | 316.596 | 363.667 | 385.149 | 409.964 | 429.855 |
| Denarna sredstva in ustrezniki | 159.086 | 363.667 | 385.149 | 409.964 | 429.855 |
| Prepaid Expenses | 4.929 | 3.352 | 3.814 | 2.313 | 2.472 |
| Total Assets | 363.676 | 380.183 | 399.728 | 421.289 | 432.91 |
| Property/Plant/Equipment, Total - Net | 6.967 | 3.397 | 3.362 | 0.167 | 0.047 |
| Property/Plant/Equipment, Total - Gross | 7.088 | 3.46 | 3.401 | 0.2 | 0.077 |
| Accumulated Depreciation, Total | -0.121 | -0.063 | -0.039 | -0.033 | -0.03 |
| Other Long Term Assets, Total | 10.075 | 9.767 | 7.403 | 8.845 | 0.536 |
| Total Current Liabilities | 15.308 | 15.295 | 12.488 | 13.979 | 14.129 |
| Accounts Payable | 5.133 | 3.764 | 3.683 | 5.806 | 7.35 |
| Accrued Expenses | 9.746 | 11.102 | 8.376 | 7.744 | 2.735 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0.429 | 0.429 | 0.429 | 0.429 | 0.095 |
| Other Current Liabilities, Total | 3.949 | ||||
| Total Liabilities | 20.08 | 17.134 | 14.556 | 16.275 | 14.426 |
| Total Long Term Debt | 0.175 | 0.28 | 0.385 | 0.489 | 0.131 |
| Capital Lease Obligations | 0.175 | 0.28 | 0.385 | 0.489 | 0.131 |
| Other Liabilities, Total | 4.597 | 1.559 | 1.683 | 1.807 | 0.166 |
| Total Equity | 343.596 | 363.049 | 385.172 | 405.014 | 418.484 |
| Redeemable Preferred Stock | 0 | ||||
| Common Stock | 0.041 | 0.041 | 0.04 | 0.04 | 0.04 |
| Additional Paid-In Capital | 570.679 | 564.993 | 558.679 | 553.955 | 551.151 |
| Retained Earnings (Accumulated Deficit) | -226.518 | -201.985 | -173.547 | -148.981 | -132.707 |
| Total Liabilities & Shareholders’ Equity | 363.676 | 380.183 | 399.728 | 421.289 | 432.91 |
| Total Common Shares Outstanding | 40.6566 | 40.5871 | 40.4863 | 40.3253 | 40.2086 |
| Kratkoročne naložbe | 157.51 | ||||
| Long Term Investments | 25.109 | ||||
| Other Equity, Total | -0.606 |
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
| Čisti prihodki/začetna postavka | -83.463 | -45.74 | -19.243 | -13.731 |
| Denarna sredstva iz poslovanja | -68.101 | -38.289 | -14.249 | -13.19 |
| Denarna sredstva iz poslovanja | 0.051 | 0.202 | 0.429 | 0.431 |
| Nedenarne postavke | 19.338 | 7.002 | 0.308 | 0.269 |
| Spremembe v obratnem kapitalu | -4.027 | 0.247 | 4.257 | -0.159 |
| Denarna sredstva pri naložbenju | -4.923 | 0.61 | -0.353 | -0.653 |
| Kapitalski izdatki | -4.923 | -0.031 | -0.353 | -0.653 |
| Denarna sredstva pri financiranju | 2.472 | 462.881 | 15.357 | 0.001 |
| Izdaja (odplačilo) delnic, neto | 2.753 | 473.235 | 9.44 | 0.001 |
| Izdaja (odplačilo) dolga, neto | -0.281 | 0 | 5.917 | 0 |
| Neto sprememba denarnih sredstev | -70.552 | 425.202 | 0.755 | -13.842 |
| Cash Taxes Paid | 0.274 | 0.047 | ||
| Denarna sredstva Plačane obresti | 0.011 | 0.427 | ||
| Celotne druge postavke denarnih tokov pri naložbenju | 0.641 | |||
| Postavke denarnega toka pri financiranju | -10.354 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -24.533 | -83.463 | -55.025 | -30.459 | -14.185 |
| Cash From Operating Activities | -20.674 | -68.101 | -50.613 | -25.757 | -5.135 |
| Cash From Operating Activities | 0.058 | 0.051 | 0.017 | 0.011 | 0.005 |
| Non-Cash Items | 5.926 | 19.338 | 8.688 | 4.241 | 1.858 |
| Cash Interest Paid | 0 | 0.011 | 0.007 | 0.003 | 0 |
| Changes in Working Capital | -2.125 | -4.027 | -4.293 | 0.45 | 7.187 |
| Cash From Investing Activities | -183.921 | -4.923 | -0.405 | -0.007 | -0.007 |
| Capital Expenditures | -0.589 | -4.923 | -0.405 | -0.007 | -0.007 |
| Cash From Financing Activities | 0.08 | 2.472 | 1.948 | 1.509 | 0.778 |
| Issuance (Retirement) of Stock, Net | 0.185 | 2.753 | 2.125 | 1.582 | 0.778 |
| Net Change in Cash | -204.515 | -70.552 | -49.07 | -24.255 | -4.364 |
| Cash Taxes Paid | 0 | 0.274 | 0.274 | 0.274 | |
| Financing Cash Flow Items | 0 | 0 | |||
| Issuance (Retirement) of Debt, Net | -0.105 | -0.281 | -0.177 | -0.073 | |
| Other Investing Cash Flow Items, Total | -183.332 | 0 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| VenBio Partners LLC | Private Equity | 23.8003 | 9699925 | 0 | 2022-12-31 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 14.9987 | 6112789 | 1482504 | 2022-12-31 | LOW |
| Lightstone Ventures, L.P. | Investment Advisor | 11.1076 | 4526963 | -194027 | 2022-03-31 | LOW |
| Vivo Capital, LLC | Venture Capital | 10.3546 | 4220048 | 0 | 2022-12-31 | MED |
| OrbiMed Advisors, LLC | Investment Advisor/Hedge Fund | 7.0445 | 2871000 | 0 | 2022-12-31 | LOW |
| Logos Global Management LLC | Investment Advisor | 5.7651 | 2349600 | -621752 | 2022-12-31 | HIGH |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 3.7051 | 1510050 | 40991 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.4941 | 1424043 | 14289 | 2022-12-31 | LOW |
| Eventide Asset Management, LLC | Investment Advisor | 2.2132 | 902000 | 0 | 2022-12-31 | MED |
| Cormorant Asset Management, LP | Hedge Fund | 1.5018 | 612079 | -100000 | 2022-12-31 | MED |
| Redmile Group, LLC | Investment Advisor/Hedge Fund | 1.4905 | 607470 | -144627 | 2022-12-31 | LOW |
| Pons (Jaume) | Individual Investor | 1.3244 | 539746 | -3232 | 2022-12-29 | LOW |
| Invus Public Equities Advisors, LLC | Investment Advisor | 1.2268 | 500000 | 0 | 2022-12-31 | LOW |
| Morgan Stanley & Co. LLC | Research Firm | 1.171 | 477236 | 90049 | 2022-12-31 | MED |
| Federated Hermes MDTA LLC | Investment Advisor/Hedge Fund | 1.1386 | 464029 | -685 | 2022-12-31 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.0117 | 412309 | 18988 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.9656 | 393550 | 8987 | 2022-12-31 | LOW |
| DWS Investments UK Limited | Investment Advisor | 0.84 | 342355 | 142 | 2022-12-31 | MED |
| Pier Capital, LLC | Investment Advisor | 0.667 | 271848 | -769 | 2022-12-31 | MED |
| Randolph (Sophia) | Individual Investor | 0.6631 | 270253 | 44857 | 2022-12-29 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
Trgovalna provizija
0
- 1:1
Vzvod
1:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
ALX Oncology Holdings Inc. Company profile
O družbi ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc. je imunoonkološko podjetje v klinični fazi. Družba se osredotoča na to, da bolnikom omogoči boj proti raku z razvojem terapij, ki blokirajo pot kontrolne točke CD47 (cluster of differentiation 47) ter povezujejo prirojeni in prilagodljivi imunski sistem. Družba razvija zaviralec kontrolne točke, ki je zasnovan tako, da ima afiniteto do CD47 in se izogne omejitvam zaradi hematološke toksičnosti, ki so značilne za druge pristope blokiranja CD47. Njen vodilni kandidat za izdelek, ALX148, je terapevtski izdelek za blokiranje CD47. ALX148 je fuzijski protein, ki združuje vezivno domeno CD47 z njegovo inaktivirano fragmentno kristalizabilno domeno (Fc). Vezavna domena CD47 v zdravilu ALX148 je afinitetno okrepljena zunajcelična domena signalnega regulatornega proteina alfa (SIRPa), proteina, ki je naravni receptor za CD47 na mieloidnih celicah. Njegovi programi so osredotočeni na ciljanje CD47 pri različnih onkoloških indikacijah.
| Industry: | Bio Therapeutic Drugs |
323 Allerton Avenue
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com